RACHAEL LOUDON-CASTILLO: Open Payments
NPI 1992376438 · TAFT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$103 in 5 payments from 4 companies in 2025. Trend: 2023 $106 · 2024 $86 · 2025 $103
Food & beverage: $103
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: UZEDY, INVEGA SUSTENNA, CAPLYTA, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
